Results 61 to 70 of about 110,621 (200)
Applying aryltrifluoroborates as PET imaging agents
, 2013 This dissertation is focused on applying aryltrifluoroborates (ArBF₃s) as PET imaging agents. Several aspects of this new ¹⁸F-labeling technique are addressed. These include the hydrolytic stability of heteroaryltrifluoroborates (HetArBF₃s), the fluoridation of arylboronic acids/esters and the radiosyntheses of several ¹⁸F-ArBF₃ labeled biomolecules ...
openaire +1 more source
The role of non-FDG agents in PET imaging of bladder cancer
Seminars in Nuclear MedicineBladder cancer (BC) poses significant diagnostic challenges for molecular imaging, as [18F]FDG PET/CT demonstrates not only intense urinary excretion that obscures pelvic lesions but also inherently limited diagnostic accuracy in differentiating tumor from inflammation and in detecting small or low-grade lesions.
Alireza Safarian +9 more
openaire +2 more sources
Agent-MIRA: AI-orchestrated medical imaging agent for PET image retrieval and assistance
Computerized Medical Imaging and GraphicsReporting on medical images can be time-consuming, especially in high-volume clinical settings. AI-agents designated to specific medical imaging tasks can potentially lead to improvements in clinical workflows. We present a prototype AI-agent to support clinical decision making by retrieving medical images which best match the patient images based on ...
Rajat Vashistha +6 more
openaire +3 more sources
Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18 [PDF]
Journal of Nuclear Medicine, 2017 Alzheimer disease (AD) is characterized by β-amyloid (Aβ) plaques and tau neurofibrillary tangles. There are several PET imaging biomarkers for Aβ including 11C-PiB and 18F-florbetapir. Recently, PET tracers for tau neurofibrillary tangles have become available and have shown utility in detection and monitoring of neurofibrillary pathology over time ...
Michael D, Devous +10 more
openaire +2 more sources
IMAGING OF THE CARDIOVASCULAR SYSTEM
Artery Research, 2013 MR and PET vessel wall imaging have progressed substantially in the past decade and considerable technical improvements have been made in image acquisition and the development of cell and protein specific contrast agents that allow plaque ...
Rene Botnar
doaj +1 more source
EJNMMI Physics, 2022 Background PET/MRI is an attractive imaging modality due to the complementary nature of MRI and PET. Obtaining high quality small animal PET/MRI results is key for the translation of novel PET/MRI agents and techniques to the radiology clinic.
Alyssa C. Pollard +5 more
doaj +1 more source
Anesthesia in PET/MRI. Challenges for the Anesthesiologist: A Narrative Review
Journal of Neuroanaesthesiology and Critical CarePositron emission tomography magnetic resonance imaging (PET/MRI) is an advanced imaging modality that combines metabolic information obtained from PET with anatomical and functional details obtained from MRI.
Sudhir Venkataramaiah +2 more
doaj +1 more source
Granzyme B PET Imaging of the Innate Immune Response
Molecules, 2020 The human immune system is a complex system which protects against invaders and maintains tissue homeostasis. It is broadly divided into the innate and adaptive branches. Granzyme B is serine protease that plays an important role in both and can serve as
Kathleen M. Capaccione +4 more
doaj +1 more source
Supramolecular rotaxane-based imaging agents targeting cancer biomarkers
, 2022 Mechanically interlocked molecules present opportunities to construct therapeutic drugs and diagnostic imaging agents but harnessing supramolecular chemistry to make biologically active molecules in water is a challenge.
Faustine, d\u27Orchymont +1 more
core +1 more source
In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol [PDF]
EJNMMI Research, 2014 The purpose of the study was to evaluate the applicability of (18) F-labelled amyloid imaging positron emission tomography (PET) agent [ (18) F]flutemetamol to detect changes in brain beta-amyloid (Aβ) deposition in vivo in APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer's disease.
Snellman, Anniina +9 more
openaire +5 more sources